AC Immune
Coralie Vallet is a Senior Scientist specializing in in vitro ADME and DMPK at AC Immune since March 2021, where responsibilities include leading DMPK projects, collaborating with CROs on study design and execution, and overseeing data analysis and sharing among teams. Prior experience includes a role as Preclinical Senior Scientist at GSK, overseeing activities in pain relief and respiratory projects, and leading cross-functional teams in project planning and data reporting. Coralie has also worked as a Research Scientist at UCB, conducting clearance determinations, and held additional roles in project management and research at GSK and Hôpital Edouard Herriot. Educational credentials include a PhD in Pharmaceutical and Biomedical Sciences from Université catholique de Louvain and various certifications in climbing instruction and work safety.
This person is not in any teams
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.